CN110872582B - A cold-adapted peroxide reductase and its encoding gene and application - Google Patents
A cold-adapted peroxide reductase and its encoding gene and application Download PDFInfo
- Publication number
- CN110872582B CN110872582B CN201811016358.8A CN201811016358A CN110872582B CN 110872582 B CN110872582 B CN 110872582B CN 201811016358 A CN201811016358 A CN 201811016358A CN 110872582 B CN110872582 B CN 110872582B
- Authority
- CN
- China
- Prior art keywords
- psprx
- cold
- peroxide reductase
- gene
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000002978 peroxides Chemical class 0.000 title claims abstract description 27
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 21
- 239000013604 expression vector Substances 0.000 claims abstract description 10
- 238000003259 recombinant expression Methods 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 6
- 230000004792 oxidative damage Effects 0.000 claims abstract description 6
- 241000588724 Escherichia coli Species 0.000 claims abstract description 5
- 241000894006 Bacteria Species 0.000 claims description 9
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 4
- 238000000855 fermentation Methods 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 238000003745 diagnosis Methods 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 108090000854 Oxidoreductases Proteins 0.000 abstract description 17
- 102000004316 Oxidoreductases Human genes 0.000 abstract description 14
- 239000002537 cosmetic Substances 0.000 abstract description 6
- 244000005700 microbiome Species 0.000 abstract description 6
- 102000003992 Peroxidases Human genes 0.000 abstract description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 abstract 2
- 241000557299 Psychrobacter sp. Species 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 11
- 101000573971 Chattonella marina var. antiqua 2-cysteine peroxiredoxin, chloroplastic Proteins 0.000 description 6
- 150000001413 amino acids Chemical group 0.000 description 6
- 238000000746 purification Methods 0.000 description 5
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 238000001042 affinity chromatography Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 235000019750 Crude protein Nutrition 0.000 description 2
- 230000028937 DNA protection Effects 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 108010047199 superoxide reductase Proteins 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NWVVKQZOVSTDBQ-CIUDSAMLSA-N Ala-Glu-Arg Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NWVVKQZOVSTDBQ-CIUDSAMLSA-N 0.000 description 1
- GGNHBHYDMUDXQB-KBIXCLLPSA-N Ala-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)N GGNHBHYDMUDXQB-KBIXCLLPSA-N 0.000 description 1
- PXAFZDXYEIIUTF-LKTVYLICSA-N Ala-Trp-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O PXAFZDXYEIIUTF-LKTVYLICSA-N 0.000 description 1
- KHGPWGKPYHPOIK-QWRGUYRKSA-N Asp-Gly-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O KHGPWGKPYHPOIK-QWRGUYRKSA-N 0.000 description 1
- QNMKWNONJGKJJC-NHCYSSNCSA-N Asp-Leu-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O QNMKWNONJGKJJC-NHCYSSNCSA-N 0.000 description 1
- RVMXMLSYBTXCAV-VEVYYDQMSA-N Asp-Pro-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O RVMXMLSYBTXCAV-VEVYYDQMSA-N 0.000 description 1
- GGBQDSHTXKQSLP-NHCYSSNCSA-N Asp-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N GGBQDSHTXKQSLP-NHCYSSNCSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- SMEYEQDCCBHTEF-FXQIFTODSA-N Cys-Pro-Ala Chemical compound [H]N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O SMEYEQDCCBHTEF-FXQIFTODSA-N 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- KDXKFBSNIJYNNR-YVNDNENWSA-N Gln-Glu-Ile Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KDXKFBSNIJYNNR-YVNDNENWSA-N 0.000 description 1
- YKLNMGJYMNPBCP-ACZMJKKPSA-N Glu-Asn-Asp Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N YKLNMGJYMNPBCP-ACZMJKKPSA-N 0.000 description 1
- WRNAXCVRSBBKGS-BQBZGAKWSA-N Glu-Gly-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O WRNAXCVRSBBKGS-BQBZGAKWSA-N 0.000 description 1
- XOIATPHFYVWFEU-DCAQKATOSA-N Glu-His-Gln Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N XOIATPHFYVWFEU-DCAQKATOSA-N 0.000 description 1
- IVGJYOOGJLFKQE-AVGNSLFASA-N Glu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N IVGJYOOGJLFKQE-AVGNSLFASA-N 0.000 description 1
- QRWPTXLWHHTOCO-DZKIICNBSA-N Glu-Val-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O QRWPTXLWHHTOCO-DZKIICNBSA-N 0.000 description 1
- OCQUNKSFDYDXBG-QXEWZRGKSA-N Gly-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N OCQUNKSFDYDXBG-QXEWZRGKSA-N 0.000 description 1
- LHRXAHLCRMQBGJ-RYUDHWBXSA-N Gly-Glu-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CN LHRXAHLCRMQBGJ-RYUDHWBXSA-N 0.000 description 1
- JSNNHGHYGYMVCK-XVKPBYJWSA-N Gly-Glu-Val Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O JSNNHGHYGYMVCK-XVKPBYJWSA-N 0.000 description 1
- HMHRTKOWRUPPNU-RCOVLWMOSA-N Gly-Ile-Gly Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O HMHRTKOWRUPPNU-RCOVLWMOSA-N 0.000 description 1
- PTIIBFKSLCYQBO-NHCYSSNCSA-N Gly-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CN PTIIBFKSLCYQBO-NHCYSSNCSA-N 0.000 description 1
- LLWQVJNHMYBLLK-CDMKHQONSA-N Gly-Thr-Phe Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LLWQVJNHMYBLLK-CDMKHQONSA-N 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- UOAVQQRILDGZEN-SRVKXCTJSA-N His-Asp-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O UOAVQQRILDGZEN-SRVKXCTJSA-N 0.000 description 1
- WGVPDSNCHDEDBP-KKUMJFAQSA-N His-Asp-Phe Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WGVPDSNCHDEDBP-KKUMJFAQSA-N 0.000 description 1
- ZZLWLWSUIBSMNP-CIUDSAMLSA-N His-Asp-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O ZZLWLWSUIBSMNP-CIUDSAMLSA-N 0.000 description 1
- JSQIXEHORHLQEE-MEYUZBJRSA-N His-Phe-Thr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JSQIXEHORHLQEE-MEYUZBJRSA-N 0.000 description 1
- ZHMZWSFQRUGLEC-JYJNAYRXSA-N His-Tyr-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZHMZWSFQRUGLEC-JYJNAYRXSA-N 0.000 description 1
- 101000619708 Homo sapiens Peroxiredoxin-6 Proteins 0.000 description 1
- HTDRTKMNJRRYOJ-SIUGBPQLSA-N Ile-Gln-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HTDRTKMNJRRYOJ-SIUGBPQLSA-N 0.000 description 1
- DVRDRICMWUSCBN-UKJIMTQDSA-N Ile-Gln-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N DVRDRICMWUSCBN-UKJIMTQDSA-N 0.000 description 1
- PHIXPNQDGGILMP-YVNDNENWSA-N Ile-Glu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N PHIXPNQDGGILMP-YVNDNENWSA-N 0.000 description 1
- SVBAHOMTJRFSIC-SXTJYALSSA-N Ile-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)O)N SVBAHOMTJRFSIC-SXTJYALSSA-N 0.000 description 1
- RENBRDSDKPSRIH-HJWJTTGWSA-N Ile-Phe-Met Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(=O)O RENBRDSDKPSRIH-HJWJTTGWSA-N 0.000 description 1
- VGSPNSSCMOHRRR-BJDJZHNGSA-N Ile-Ser-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N VGSPNSSCMOHRRR-BJDJZHNGSA-N 0.000 description 1
- HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 1
- HFBCHNRFRYLZNV-GUBZILKMSA-N Leu-Glu-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HFBCHNRFRYLZNV-GUBZILKMSA-N 0.000 description 1
- POZULHZYLPGXMR-ONGXEEELSA-N Leu-Gly-Val Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O POZULHZYLPGXMR-ONGXEEELSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- YRWCPXOFBKTCFY-NUTKFTJISA-N Lys-Ala-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCCCN)N YRWCPXOFBKTCFY-NUTKFTJISA-N 0.000 description 1
- DLCAXBGXGOVUCD-PPCPHDFISA-N Lys-Thr-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DLCAXBGXGOVUCD-PPCPHDFISA-N 0.000 description 1
- GVKINWYYLOLEFQ-XIRDDKMYSA-N Lys-Trp-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CO)C(O)=O GVKINWYYLOLEFQ-XIRDDKMYSA-N 0.000 description 1
- VHGIWFGJIHTASW-FXQIFTODSA-N Met-Ala-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O VHGIWFGJIHTASW-FXQIFTODSA-N 0.000 description 1
- WXHHTBVYQOSYSL-FXQIFTODSA-N Met-Ala-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O WXHHTBVYQOSYSL-FXQIFTODSA-N 0.000 description 1
- GETCJHFFECHWHI-QXEWZRGKSA-N Met-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCSC)N GETCJHFFECHWHI-QXEWZRGKSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- 102000007456 Peroxiredoxin Human genes 0.000 description 1
- 102100022239 Peroxiredoxin-6 Human genes 0.000 description 1
- KIEPQOIQHFKQLK-PCBIJLKTSA-N Phe-Asn-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KIEPQOIQHFKQLK-PCBIJLKTSA-N 0.000 description 1
- GTMSCDVFQLNEOY-BZSNNMDCSA-N Phe-Tyr-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N GTMSCDVFQLNEOY-BZSNNMDCSA-N 0.000 description 1
- SJRQWEDYTKYHHL-SLFFLAALSA-N Phe-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CC=CC=C3)N)C(=O)O SJRQWEDYTKYHHL-SLFFLAALSA-N 0.000 description 1
- WFHYFCWBLSKEMS-KKUMJFAQSA-N Pro-Glu-Phe Chemical compound N([C@@H](CCC(=O)O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C(=O)[C@@H]1CCCN1 WFHYFCWBLSKEMS-KKUMJFAQSA-N 0.000 description 1
- LNICFEXCAHIJOR-DCAQKATOSA-N Pro-Ser-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O LNICFEXCAHIJOR-DCAQKATOSA-N 0.000 description 1
- IURWWZYKYPEANQ-HJGDQZAQSA-N Pro-Thr-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O IURWWZYKYPEANQ-HJGDQZAQSA-N 0.000 description 1
- 101150035060 Prx gene Proteins 0.000 description 1
- SMIDBHKWSYUBRZ-ACZMJKKPSA-N Ser-Glu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O SMIDBHKWSYUBRZ-ACZMJKKPSA-N 0.000 description 1
- SZRNDHWMVSFPSP-XKBZYTNZSA-N Ser-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)N)O SZRNDHWMVSFPSP-XKBZYTNZSA-N 0.000 description 1
- JGUWRQWULDWNCM-FXQIFTODSA-N Ser-Val-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O JGUWRQWULDWNCM-FXQIFTODSA-N 0.000 description 1
- TWLMXDWFVNEFFK-FJXKBIBVSA-N Thr-Arg-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O TWLMXDWFVNEFFK-FJXKBIBVSA-N 0.000 description 1
- XDARBNMYXKUFOJ-GSSVUCPTSA-N Thr-Asp-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XDARBNMYXKUFOJ-GSSVUCPTSA-N 0.000 description 1
- MECLEFZMPPOEAC-VOAKCMCISA-N Thr-Leu-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N)O MECLEFZMPPOEAC-VOAKCMCISA-N 0.000 description 1
- NWECYMJLJGCBOD-UNQGMJICSA-N Thr-Phe-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O NWECYMJLJGCBOD-UNQGMJICSA-N 0.000 description 1
- XHWCDRUPDNSDAZ-XKBZYTNZSA-N Thr-Ser-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N)O XHWCDRUPDNSDAZ-XKBZYTNZSA-N 0.000 description 1
- DDNIHOWRDOXXPF-NGZCFLSTSA-N Val-Asp-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N DDNIHOWRDOXXPF-NGZCFLSTSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019261 food antioxidant Nutrition 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010081551 glycylphenylalanine Proteins 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 108010090333 leucyl-lysyl-proline Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108010016686 methionyl-alanyl-serine Proteins 0.000 description 1
- 108010068488 methionylphenylalanine Proteins 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 108030002458 peroxiredoxin Proteins 0.000 description 1
- 238000002205 phenol-chloroform extraction Methods 0.000 description 1
- 108010064486 phenylalanyl-leucyl-valine Proteins 0.000 description 1
- 108010051242 phenylalanylserine Proteins 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000007727 signaling mechanism Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 108010029384 tryptophyl-histidine Proteins 0.000 description 1
- 108010020532 tyrosyl-proline Proteins 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
- C12Y111/01—Peroxidases (1.11.1)
- C12Y111/01015—Peroxiredoxin (1.11.1.15)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
本发明公开了一种适冷过氧化物酶及其编码基因与应用,其目的是提供一种适冷过氧化物还原酶及其编码基因与应用。本发明首先从南极海冰微生物嗜冷杆菌(Psychrobactersp.)中克隆了过氧化物还原酶基因PsPrx,该过氧化物还原酶的氨基酸残基序列如SEQ ID No.2所示。其表达方法是构建含有过氧化物还原酶基因PsPrx的重组表达载体,并将构建的重组表达载体导入宿主细胞(Escherichia coli),经诱导使过氧化物还原酶PsPrx基因表达。本发明的表达产物PsPrx具有突出的适冷性,稳定性较好,并具有良好的保护超螺旋DNA免受氧化损伤的能力,可应用于生物医药、化妆品和食品等相关领域。The invention discloses a cold-adapting peroxidase, its encoding gene and application, and aims to provide a cold-adapting peroxidase and its encoding gene and application. The present invention firstly clones the peroxide reductase gene PsPrx from the Antarctic sea ice microorganism Psychrobacter sp., and the amino acid residue sequence of the peroxide reductase is shown in SEQ ID No.2. The expression method is to construct a recombinant expression vector containing the peroxide reductase gene Ps Prx, and introduce the constructed recombinant expression vector into a host cell ( Escherichia coli ), and induce the expression of the peroxide reductase PsPrx gene. The expression product PsPrx of the present invention has outstanding cold adaptability, good stability, and good ability to protect supercoiled DNA from oxidative damage, and can be applied to related fields such as biomedicine, cosmetics and food.
Description
技术领域technical field
本发明属于生物技术及医药、化妆品和食品等领域,具体涉及一种适冷过氧化物还原酶及其编码基因和应用。The invention belongs to the fields of biotechnology, medicine, cosmetics, food and the like, and particularly relates to a cold-adapting peroxide reductase and its encoding gene and application.
背景技术Background technique
过氧化物还原酶(Peroxiredoxin,Prx)是一类广泛存在于真核生物与原核生物的重要的硫醇依赖的抗氧化酶类,它们能够高效降解H2O2,过氧硝酸盐及多种有机过氧化物。微生物体内的Prx主要分为3类,即1-Cys Prx,典型2-Cys Prx及非典型2-Cys Prx。典型2-Cys Prx已经被证明与控制细胞凋亡、分化和增殖的氧化信号机制有关,且可能参与免疫反应,能够作为肿瘤及癌症的生物诊断标记物。此外,基于Prx的抗氧化能力,还能够被作为食品抗氧化剂延长食品的货架期。因此,典型2-Cys Prx在化工、食品、医药等生产行业具有广泛的应用价值。Peroxiredoxin (Prx) is a class of important thiol-dependent antioxidant enzymes that widely exist in eukaryotes and prokaryotes. They can efficiently degrade H 2 O 2 , peroxynitrate and a variety of Organic peroxides. Prx in microorganisms is mainly divided into three categories, namely 1-Cys Prx, typical 2-Cys Prx and atypical 2-Cys Prx. Typical 2-Cys Prx has been shown to be involved in oxidative signaling mechanisms that control cell apoptosis, differentiation and proliferation, and may be involved in immune responses, and can be used as biomarkers for tumor and cancer diagnosis. In addition, based on the antioxidant capacity of Prx, it can also be used as a food antioxidant to extend the shelf life of food. Therefore, typical 2-Cys Prx has a wide range of application value in chemical, food, pharmaceutical and other production industries.
从动植物中提取的过氧化物还原酶易受时节、气候和地域的限制,且稳定性较差,难以直接应用于工业生产等相关领域。利用基因工程菌诱导表达是降低成本和获得具有天然活性的过氧化物还原酶有效途径。Peroxidoreductases extracted from animals and plants are easily limited by seasons, climates and regions, and have poor stability, making it difficult to directly apply to related fields such as industrial production. The use of genetically engineered bacteria to induce expression is an effective way to reduce costs and obtain peroxidoreductases with natural activity.
南极环境具有强辐射、高盐度和低温等各种极端条件的特点,环境中积累大量的氧自由基及过氧化物。而南极微生物为了适应极端环境,进化出了高效抗氧化酶系统来清除氧自由基和过氧化物等物质。因此,南极微生物是抗氧化酶基因资源的重要新来源之一。The Antarctic environment is characterized by various extreme conditions such as strong radiation, high salinity and low temperature, and a large number of oxygen free radicals and peroxides are accumulated in the environment. In order to adapt to the extreme environment, Antarctic microorganisms have evolved a high-efficiency antioxidant enzyme system to scavenge oxygen free radicals and peroxides. Therefore, Antarctic microorganisms are one of the important new sources of antioxidant enzyme gene resources.
鉴于上述论述,从南极微生物Psychrobactorsp.体内克隆出Prx为典型2-CysPrx。该基因在大肠杆菌中实现了表达,且重组过氧化物还原酶PsPrx具有保护超螺旋DNA免受氧化损伤的能力,可应用于生物医药、化妆品和食品相关领域。In view of the above discussion, Prx was cloned from Antarctic microorganism Psychrobactor sp. as a typical 2-CysPrx. The gene is expressed in Escherichia coli, and the recombinant peroxide reductase PsPrx has the ability to protect supercoiled DNA from oxidative damage, and can be used in biomedicine, cosmetics and food-related fields.
发明内容SUMMARY OF THE INVENTION
本发明所要解决的技术问题是提供一种表达法方法简单易行,表达产物易纯化且低温催化特性的过氧化物还原酶PsPrx及其编码基因和应用。The technical problem to be solved by the present invention is to provide a peroxidase reductase PsPrx and its encoding gene and application which are simple and easy to express, the expression product is easy to purify, and has low-temperature catalytic properties.
本发明的第一个目的在于提供一种适冷过氧化物还原酶基因PsPrx(典型2-CysPrx)的基因序列和由此推断的氨基酸序列。本发明的适冷过氧化物还原酶PsPrx其核苷酸序列如SEQ ID No.1所示,其氨基酸序列如SEQ ID No.2所示。该适冷过氧化物还原酶PsPrx全长567 bp,编码188个氨基酸。The first object of the present invention is to provide a gene sequence of a cold-adapted peroxide reductase gene PsPrx (typical 2-CysPrx) and an amino acid sequence deduced therefrom. The nucleotide sequence of the cold-adapted peroxide reductase PsPrx of the present invention is shown in SEQ ID No.1, and its amino acid sequence is shown in SEQ ID No.2. The cold-adapted superoxide reductase PsPrx is 567 bp in length and encodes 188 amino acids.
含有上述适冷过氧化物还原酶PsPrx的重组表达载体。The recombinant expression vector containing the above-mentioned cold-adapted peroxide reductase PsPrx.
所述的表达载体优选为pET-28a(+)。The expression vector is preferably pET-28a(+).
一种含有上述重组表达载体的基因工程菌。A genetically engineered bacterium containing the above-mentioned recombinant expression vector.
所述的工程菌优选为E.coli BL21 (DE3)。The engineering bacteria is preferably E. coli BL21 (DE3).
培养含有本发明的适冷过氧化物还原酶PsPrx编码基因的宿主细胞的培养基和培养条件均可为培养出宿主的培养基和培养条件。其中,培养所述重组宿主大肠杆菌时,在32-40 ℃下培养至OD600为0.4-0.8,培养基中加入IPTG至终浓度为0.5-1.5 mM,25-30 ℃下诱导发酵6-10 h,即可高效诱导表达适冷过氧化物还原酶PsPrx。The culture medium and culture conditions for culturing the host cells containing the gene encoding the cold-adapted peroxide reductase PsPrx of the present invention can be both the culture medium and the culture conditions for culturing the host. Wherein, when culturing the recombinant host Escherichia coli, it is cultured at 32-40 °C to an OD 600 of 0.4-0.8, IPTG is added to the medium to a final concentration of 0.5-1.5 mM, and fermentation is induced at 25-30 °C for 6-10 h, the expression of cold-adapted superoxide reductase PsPrx can be efficiently induced.
所述对表达产物适冷过氧化物还原酶PsPrx进行优化的方法优选为Ni柱亲和层析法。The method for optimizing the expression product, the cold-adapted peroxide reductase PsPrx, is preferably Ni-column affinity chromatography.
本发明的第二个目的在于提供上述PsPrx重组蛋白能保护超螺旋DNA免受氧化损伤,可应用于生物医药、化妆品和食品相关领域。The second object of the present invention is to provide that the above-mentioned PsPrx recombinant protein can protect supercoiled DNA from oxidative damage, and can be applied to the fields of biomedicine, cosmetics and food.
所以,本发明主要涉及一种适冷过氧化物还原酶PsPrx的基因序列,更具体涉及该适冷过氧化物还原酶PsPrx的氨基酸序列、重组表达载体构建,重组蛋白制备及纯化,本发明还涉及该PsPrx重组蛋白能保护超螺旋DNA免受氧化损伤,可应用于生物医药、化妆品和食品相关领域。Therefore, the present invention mainly relates to the gene sequence of a cold-adapted peroxide reductase PsPrx, more specifically, to the amino acid sequence of the cold-adapted peroxide reductase PsPrx, the construction of recombinant expression vector, the preparation and purification of recombinant protein, and the present invention also The PsPrx recombinant protein can protect the supercoiled DNA from oxidative damage, and can be applied to the fields of biomedicine, cosmetics and food.
附图说明Description of drawings
图1是嗜冷杆菌中过氧化物还原酶PsPrx的表达和纯化SDS-PAGE图。Figure 1 is an SDS-PAGE chart of the expression and purification of the peroxidoreductase PsPrx in Psychrophilic Bacillus.
图2是重组过氧化物还原酶PsPrx在FeCl3催化氧化系统中对DNA的保护分析图。Figure 2 is an analysis diagram of DNA protection by recombinant peroxide reductase PsPrx in FeCl 3 catalytic oxidation system.
具体实施方式Detailed ways
以下实施例是对本发明的说明,而不是对本发明的限制。The following examples are intended to illustrate the present invention, but not to limit the present invention.
以下实施例中未具体注明的试验方法均可按照常规方法进行,或者按照所用产品生产厂商的使用说明。下属实施例中所用的材料、试剂等,如无特殊说明,均可通过商业途径得到。The test methods that are not specifically indicated in the following examples can be carried out according to conventional methods, or according to the instructions of the used product manufacturers. The materials, reagents, etc. used in the following examples can be obtained through commercial channels unless otherwise specified.
实施例1:过氧化物还原酶基因的克隆及测序分析。Example 1: Cloning and sequencing analysis of peroxidoreductase gene.
南极微生物Psychrobactorsp.ANT206于2216E液体培养基中活化,培养至对数生长期的中后期(约4d),结合CTAB法和苯酚-氯仿抽提法提取菌株的总基因DNA。以提取的总DNA为模板,利用简并引物进行PCR。The Antarctic microorganism Psychrobactor sp. ANT206 was activated in 2216E liquid medium and cultivated to the middle and late logarithmic growth phase (about 4 days), and the total gene DNA of the strain was extracted by combining CTAB method and phenol-chloroform extraction method. PCR was performed using degenerate primers using the extracted total DNA as a template.
上游引物:5’- AMTCAGTGACADTCAG ATGGCGTCT -3’Upstream primer: 5'-AMTCAGTGACADTCAG ATGGCGTCT-3'
下游引物:5’- GSAACTGGKGCATATGTTAGATTTT -3’Downstream primer: 5'-GSAACTGGKGCATATGTTAGATTTT-3'
扩增条件为:94 ℃变性1 min,58.2 ℃退火1 min,72 ℃延伸90 s,循环30次。然后通过琼脂糖凝胶电泳检测从中寻找含有目的基因PsPrx的条带并进行测序。分析测序结果,得到一个全长为567 bp完整阅读框序列的基因,核苷酸序列如SEQIDNo.1所示,编码一个由188个氨基酸组成的蛋白质,氨基酸序列如SEQIDNo.2所示。The amplification conditions were as follows: denaturation at 94 °C for 1 min, annealing at 58.2 °C for 1 min, and extension at 72 °C for 90 s, with 30 cycles. Then, the band containing the target gene Ps Prx was detected by agarose gel electrophoresis and sequenced. Analyzing the sequencing results, a gene with a full-length reading frame of 567 bp was obtained. The nucleotide sequence is shown in SEQ ID No. 1, which encodes a protein composed of 188 amino acids, and the amino acid sequence is shown in SEQ ID No. 2.
实施例2:过氧化物还原酶基因的表达与纯化Example 2: Expression and purification of peroxidoreductase gene
根据测定的Prx的全长序列重新设计含有酶切位点的引物。The primers containing the restriction sites were redesigned according to the determined full-length sequence of Prx.
上游引物:5’-ATAGGATCCATGGCGTCTATCATCA -3’Upstream primer: 5'-ATA GGATCC ATGGCGTCTATCATCA -3'
下游引物:5’-CGCAAGCTTCGATTTTACCTACTAG -3’Downstream primer: 5'-CGC AAGCTT CGATTTTACCTACTAG -3'
划线处分别为BamHI,HindIII酶切位点。The underlined points are Bam HI and Hin dIII restriction sites, respectively.
将Prx基因与pET-28a(+)双酶切后胶回收产物按比例利用T4连接酶连接,构建重组表达载体pET-Prx。将重组表达载体转化至感受态细胞E.coli BL21 (DE3)中,进行阳性克隆筛选及酶切验证。The Prx gene and pET-28a(+) double-enzyme digested gel recovery products were ligated by T4 ligase in proportion to construct the recombinant expression vector pET-Prx. The recombinant expression vector was transformed into competent cells E.coli BL21 (DE3), and positive clones were screened and verified by enzyme digestion.
将筛选得到的重组菌株,利用IPTG诱导表达。将重组菌接种至LB培养基中,32-40℃下培养至OD600为0.4-0.8,培养基中加入IPTG至终浓度为0.5-1.5 mM,25-30 ℃下诱导发酵6-10 h。离心,收集菌体沉淀,冰浴中研磨和超声波破碎,提取粗蛋白。用Ni柱亲和层析对PsPrx重组蛋白进行纯化,进行SDS-PAGE电泳分析,最终得到单一目的条带,其分子量约为25.2 kDa。结果如图1所示,M,标准分子量蛋白marker;1,空白质粒对照;2,重组pET-Prx;3,纯化后PsPrx。Ni柱亲和层析具体实施方案如下:提取粗蛋白上Ni柱后,使用5-20 mM咪唑洗脱8-10个柱体积,40-60 mM咪唑洗脱8-10个柱体积,最后用100-500 mM咪唑洗脱8-10个柱体积,收集峰值处洗脱液,得到纯化后适冷过氧化物还原酶PsPrx。The recombinant strains obtained by screening were induced to express by IPTG. The recombinant bacteria were inoculated into LB medium, cultured at 32-40 °C until OD 600 was 0.4-0.8, IPTG was added to the medium to a final concentration of 0.5-1.5 mM, and fermentation was induced at 25-30 °C for 6-10 h. After centrifugation, the cell pellet was collected, ground in an ice bath and sonicated to extract crude protein. The PsPrx recombinant protein was purified by Ni-column affinity chromatography, and analyzed by SDS-PAGE electrophoresis. Finally, a single target band was obtained, and its molecular weight was about 25.2 kDa. The results are shown in Figure 1, M, standard molecular weight protein marker; 1, blank plasmid control; 2, recombinant pET-Prx; 3, PsPrx after purification. The specific embodiment of Ni column affinity chromatography is as follows: after extracting crude protein onto Ni column, use 5-20 mM imidazole to elute 8-10 column volumes, 40-60 mM imidazole to elute 8-10 column volumes, and finally use 5-20 mM imidazole to elute for 8-10 column volumes. 100-500 mM imidazole is eluted for 8-10 column volumes, and the eluate at the peak is collected to obtain PsPrx, which is a suitable cold peroxide reductase after purification.
实施例3:FeCl3催化氧化超螺旋DNA保护分析Example 3 : FeCl3-catalyzed oxidation of supercoiled DNA protection assay
15 μL的反应体系包含15-18 mM FeCl3,15-18 mM DTT及一定量的纯化后PsPrx在20-30 ℃下水浴2-3 h,随后加入750-1250 ng pUC19超螺旋DNA,20-30 ℃下水浴2-3 h。反应后通过琼脂糖凝胶电泳检测降解结果。结果表明,适冷过氧化物还原酶PsPrx能够保护超螺旋DNA免受金属催化氧化系统的损伤。结果如图2所示,1,pUC19质粒;2,pUC19质粒+FeCl;3,pUC19 质粒+ DTT;4,pUC19质粒+FeCl3+DTT+BSA;5,pUC19质粒+FeCl3+DTT+PsPrx (5 μg/mL);6,pUC19质粒+FeCl3+DTT+PsPrx (10 μg/mL);7,pUC19质粒+FeCl3+DTT+PsPrx (15 μg/mL);8,pUC19质粒+FeCl3+DTT+PsPrx (20 μg/mL);NF,切口状质粒DNA;SF,超螺旋状质粒DNA。该实验证明适冷过氧化物还原酶PsPrx具有良好的保护超螺旋DNA免受氧化损伤的能力,可应用于生物医药、化妆品和食品等相关领域。The 15 μL reaction system contains 15-18 mM FeCl 3 , 15-18 mM DTT and a certain amount of purified PsPrx in a water bath at 20-30 °C for 2-3 h, followed by adding 750-1250 ng pUC19 supercoiled DNA, 20- Water bath at 30 °C for 2-3 h. After the reaction, the degradation results were detected by agarose gel electrophoresis. The results show that the cold-adapted peroxidoreductase PsPrx can protect supercoiled DNA from damage by metal-catalyzed oxidation systems. The results are shown in Figure 2, 1, pUC19 plasmid; 2, pUC19 plasmid+FeCl; 3 , pUC19 plasmid+DTT; 4, pUC19 plasmid+FeCl3+DTT+BSA; 5 , pUC19 plasmid+FeCl3+DTT+PsPrx ( 5 μg/mL); 6, pUC19 plasmid+FeCl 3 +DTT+PsPrx (10 μg/mL); 7, pUC19 plasmid+FeCl 3 +DTT+PsPrx (15 μg/mL); 8, pUC19 plasmid+FeCl 3 + DTT+PsPrx (20 μg/mL); NF, nicked plasmid DNA; SF, supercoiled plasmid DNA. This experiment proves that the cold-adapted peroxide reductase PsPrx has a good ability to protect supercoiled DNA from oxidative damage, and can be used in related fields such as biomedicine, cosmetics and food.
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所做的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围。The above-mentioned embodiments are preferred embodiments of the present invention, but the embodiments of the present invention are not limited by the above-mentioned embodiments, and any other changes, modifications, substitutions, and combinations made without departing from the spirit and principle of the present invention , simplification, all should be equivalent replacement modes, and are all included in the protection scope of the present invention.
SEQUENCE LISTINGSEQUENCE LISTING
<110> 哈尔滨工业大学(威海)<110> Harbin Institute of Technology (Weihai)
<120> 一种适冷过氧化物还原酶及其编码基因与应用<120> A cold-adapted peroxide reductase and its encoding gene and application
<130> 11<130> 11
<160> 2<160> 2
<170> PatentIn version 3.5<170> PatentIn version 3.5
<210> 1<210> 1
<211> 567<211> 567
<212> DNA<212> DNA
<213> Artificial Sequence<213> Artificial Sequence
<220><220>
<223> Psychrobactor sp . ANT206<223> Psychrobactor sp. ANT206
<400> 1<400> 1
atggcgtcta tcatcaatca agaaatccca gaattttcaa cacaagcgtt ttacaacggt 60atggcgtcta tcatcaatca agaaatccca gaattttcaa cacaagcgtt ttacaacggt 60
gaattcaaaa ccatcacctc tgaagacgta aaaggcaagt ggtcgatttt catgttttac 120gaattcaaaa ccatcacctc tgaagacgta aaaggcaagt ggtcgatttt catgttttac 120
ccacacgact ttacctttgt ttgcccaact gaacttgaag acatggcaga ccattacgaa 180ccacacgact ttacctttgt ttgcccaact gaacttgaag acatggcaga ccattacgaa 180
gagctaaaaa agttaggcgt agaagtgtac tcagtatcaa cggatacgca tttcacccat 240gagctaaaaa agttaggcgt agaagtgtac tcagtatcaa cggatacgca tttcacccat 240
aaagcatggc atgattcttc agaagcaatc tccaaaattc agtacccaat gattggtgat 300aaagcatggc atgattcttc agaagcaatc tccaaaattc agtacccaat gattggtgat 300
cctactggtc gtatcacgcg tggctttaac attatgattg aagaagagca ccaagctgag 360cctactggtc gtatcacgcg tggctttaac attatgattg aagaagagca ccaagctgag 360
cgcggtacat tcttagtaga tcctgatggc tttattcaag ttgctgagat tcatgacctc 420cgcggtacat tcttagtaga tcctgatggc tttattcaag ttgctgagat tcatgacctc 420
ggtattggcc gtagtgcaaa agatatgctg cgtaaagtaa aagcggcaca gtatgttcgt 480ggtattggcc gtagtgcaaa agatatgctg cgtaaagtaa aagcggcaca gtatgttcgt 480
gaaaacgacg gcgaagtttg cccagccgct tgggaagagg gtcaagagac tttaaaacca 540gaaaacgacg gcgaagtttg cccagccgct tgggaagagg gtcaagagac tttaaaacca 540
agtcttgatc tagtaggtaa aatctaa 567agtcttgatc tagtaggtaa aatctaa 567
<210> 2<210> 2
<211> 188<211> 188
<212> PRT<212> PRT
<213> Artificial Sequence<213> Artificial Sequence
<220><220>
<223> Psychrobactor sp . ANT206<223> Psychrobactor sp. ANT206
<400> 2<400> 2
Met Ala Ser Ile Ile Asn Gln Glu Ile Pro Glu Phe Ser Thr Gln AlaMet Ala Ser Ile Ile Asn Gln Glu Ile Pro Glu Phe Ser Thr Gln Ala
1 5 10 151 5 10 15
Phe Tyr Asn Gly Glu Phe Lys Thr Ile Thr Ser Glu Asp Val Lys GlyPhe Tyr Asn Gly Glu Phe Lys Thr Ile Thr Ser Glu Asp Val Lys Gly
20 25 30 20 25 30
Lys Trp Ser Ile Phe Met Phe Tyr Pro His Asp Phe Thr Phe Val CysLys Trp Ser Ile Phe Met Phe Tyr Pro His Asp Phe Thr Phe Val Cys
35 40 45 35 40 45
Pro Thr Glu Leu Glu Asp Met Ala Asp His Tyr Glu Glu Leu Lys LysPro Thr Glu Leu Glu Asp Met Ala Asp His Tyr Glu Glu Leu Lys Lys
50 55 60 50 55 60
Leu Gly Val Glu Val Tyr Ser Val Ser Thr Asp Thr His Phe Thr HisLeu Gly Val Glu Val Tyr Ser Val Ser Thr Asp Thr His Phe Thr His
65 70 75 8065 70 75 80
Lys Ala Trp His Asp Ser Ser Glu Ala Ile Ser Lys Ile Gln Tyr ProLys Ala Trp His Asp Ser Ser Glu Ala Ile Ser Lys Ile Gln Tyr Pro
85 90 95 85 90 95
Met Ile Gly Asp Pro Thr Gly Arg Ile Thr Arg Gly Phe Asn Ile MetMet Ile Gly Asp Pro Thr Gly Arg Ile Thr Arg Gly Phe Asn Ile Met
100 105 110 100 105 110
Ile Glu Glu Glu His Gln Ala Glu Arg Gly Thr Phe Leu Val Asp ProIle Glu Glu Glu His Gln Ala Glu Arg Gly Thr Phe Leu Val Asp Pro
115 120 125 115 120 125
Asp Gly Phe Ile Gln Val Ala Glu Ile His Asp Leu Gly Ile Gly ArgAsp Gly Phe Ile Gln Val Ala Glu Ile His Asp Leu Gly Ile Gly Arg
130 135 140 130 135 140
Ser Ala Lys Asp Met Leu Arg Lys Val Lys Ala Ala Gln Tyr Val ArgSer Ala Lys Asp Met Leu Arg Lys Val Lys Ala Ala Gln Tyr Val Arg
145 150 155 160145 150 155 160
Glu Asn Asp Gly Glu Val Cys Pro Ala Ala Trp Glu Glu Gly Gln GluGlu Asn Asp Gly Glu Val Cys Pro Ala Ala Trp Glu Glu Gly Gln Glu
165 170 175 165 170 175
Thr Leu Lys Pro Ser Leu Asp Leu Val Gly Lys IleThr Leu Lys Pro Ser Leu Asp Leu Val Gly Lys Ile
180 185 180 185
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811016358.8A CN110872582B (en) | 2018-09-01 | 2018-09-01 | A cold-adapted peroxide reductase and its encoding gene and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811016358.8A CN110872582B (en) | 2018-09-01 | 2018-09-01 | A cold-adapted peroxide reductase and its encoding gene and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110872582A CN110872582A (en) | 2020-03-10 |
CN110872582B true CN110872582B (en) | 2022-08-02 |
Family
ID=69716426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811016358.8A Expired - Fee Related CN110872582B (en) | 2018-09-01 | 2018-09-01 | A cold-adapted peroxide reductase and its encoding gene and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110872582B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111440807A (en) * | 2020-04-07 | 2020-07-24 | 上海海洋大学 | Shewanella WP3 mutant strain with high production of low temperature catalase and its construction method and application |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102346186B (en) * | 2011-01-24 | 2015-05-27 | 中国人民解放军第三军医大学 | ELISA kit for detecting peroxiredoxin IV antibody in biological sample, method and use thereof |
CN103255113B (en) * | 2013-05-21 | 2015-01-14 | 中国人民解放军第二军医大学 | Cyanea capillata peroxide reductase as well as encoding gene and application thereof |
CN108060146A (en) * | 2018-02-11 | 2018-05-22 | 中国农业科学院植物保护研究所 | Migratory locusts peroxiredoxin PRX5 and its encoding gene and application |
-
2018
- 2018-09-01 CN CN201811016358.8A patent/CN110872582B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN110872582A (en) | 2020-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110527677A (en) | Zearalenone hydrolyzes enzyme mutant ZHDM2 and its encoding gene and application | |
CN111004794B (en) | Subtilisin E mutant with improved thermal stability and application thereof | |
CN105062992A (en) | Endolysin and polynucleotide for encoding the same | |
CN110872582B (en) | A cold-adapted peroxide reductase and its encoding gene and application | |
CN102618517A (en) | Zearalenone (ZEN) toxin degrading enzyme for acinetobacter and coding gene and applications of ZEN toxin degrading enzyme | |
CN105002192B (en) | A kind of malic enzyme gene RKME1 and its recombinant expression carrier | |
CN104450632B (en) | Amino acid sequence capable of improving heat-resistance temperature and heat stability of SOD and application thereof | |
CN101605807A (en) | Improved Recombinant Human Arginine I Expression System | |
CN107164346A (en) | A kind of alkaline salt tolerant Pullulanase PulA and its gene and application | |
CN113403292B (en) | Copper-containing amine oxidase of degradable biogenic amine from polysaccharide-containing fungus and application thereof | |
CN104673808B (en) | A kind of malic enzyme gene and its recombinant expression carrier | |
CN105368802B (en) | A kind of salt tolerant esterase and its encoding gene and application | |
CN111466511B (en) | Compositions containing a desepoxyprotease and methods of detoxification | |
CN107653257A (en) | A kind of encoding gene, recombinant expression carrier and the application of nicotinamide mononucleotide adenylyl transferase | |
CN109628429B (en) | Extreme-halophilic surfactant-resistant non-calcium ion-dependent alpha-amylase and gene and application thereof | |
CN116478973A (en) | CbTPS6 and its related biomaterials and applications | |
CN111826384B (en) | A cold-adapting ribonuclease R and its encoding gene and application | |
CN111826359B (en) | A cold-adaptive and salt-tolerant nitroreductase and its encoding gene and application | |
CN106754768B (en) | A kind of lipoxygenase mutant with improved thermostability and construction method thereof | |
CN111411115B (en) | Genes and methods for improving rhizobia | |
KR101713885B1 (en) | Lipase with sn-1 specificity and method for production thereof | |
CN109251913A (en) | A kind of mannosan enzyme mutant DeP41P42 and its application | |
CN113684195B (en) | A kind of sterol esterase and its encoding gene and its mutant | |
KR101828080B1 (en) | Cold-Active Lipase from Psychrobacter sp. | |
CN104946608A (en) | Cold-adapted superoxide dismutase and coding gene and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20220802 |
|
CF01 | Termination of patent right due to non-payment of annual fee |